WIC
VERV

Water Island Capital’s Verve Therapeutics VERV Stock Holding History

Water Island Capital’s Portfolio VERV Stock Details VERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-335,593
Closed -$3.77M – 128
2025
Q2 		$3.77M Buy
+335,593
New +$1.91M 0.54% 48

Other funds holding VERV

GCM
Greenland Capital Management New York $787M AUM 40.68% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
BIG
Brooklyn Investment Group Brooklyn, New York $3.2B AUM 26.32% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Water Island Capital's VERV Position: Q3 2025 in Review

Water Island Capital sold out of Verve Therapeutics (VERV) in Q3 2025, closing a stake of 335,593 shares — an estimated $3.77M sold.

Water Island Capital first reported a position in VERV in Q2 2025 and held it in 1 quarter. The position peaked at $3.77M in Q2 2025. 6 funds tracked by Wall St. Rank hold VERV as of Q3 2025.

  • Water Island Capital reported no remaining Verve Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Water Island Capital sold 335,593 Verve Therapeutics shares in Q3 2025, an estimated $3.77M.
  • Water Island Capital first reported a position in Verve Therapeutics in Q2 2025 and held it in 1 quarter.
  • Water Island Capital's Verve Therapeutics position peaked at $3.77M in Q2 2025.
  • 6 funds tracked by Wall St. Rank held Verve Therapeutics as of Q3 2025.

Based on Water Island Capital's 13F filing for Q3 2025, filed 14 Nov 2025.